MAY 28, 2014 1:30 PM PDT

Lowering Blood Culture Contamination Rates Using an Evidence-Based Medicine Approach

Speaker
  • President, CEO and Laboratory Director, Microbiology Specialists Incorporated
    Biography
      Alice Schauer Weissfeld, Ph.D., D(ABMM), F(AAM), is the President, CEO, and Laboratory Director of Microbiology Specialists Incorporated, a reference laboratory that she cofounded in 1984. She earned her doctoral degree in microbiology at Rutgers University, New Brunswick, NJ, and completed a postdoctoral fellowship in Public Health and Medical Laboratory Microbiology at Baylor College of Medicine, Houston, TX. She is a Diplomate of the American Board of Medical Microbiology of the American Academy of Microbiology and was elected to a fellowship in the American Academy of Microbiology in 1986.  Dr. Weissfeld is an author of the last three editions of Bailey and Scotts Diagnostic Microbiology, an editor of Clinical Microbiology Newsletter, and a member of the Professional Affairs Committee of ASM.  Dr. Weissfeld is currently a member of ASMs new Professional Practice Committee and Chair of its Subcommittee on Evidence-Based Medicine.  She has been the ASM delegate to the U.S. Pharmacopeia since 2005 and has worked with its Expert Panel to establish best microbiological practices for compounded sterile preparations.  Dr. Weissfeld has won three ASM national awards, the ABMM/ABMLI Professional Recognition Award (1999), the bioMrieux Sonnenwirth Award for Leadership in Clinical Microbiology (2004), and the ASM Founders Distinguished Service Award (2013).

    Abstract

    Blood culture contamination is a huge problem in the hospital. If strict aseptic technique is not used, patients can be treated unnecessarily, leading to complications from intravenous antimicrobial use. Unnecessary treatment costs hundreds of thousands of dollars per year. A number of changes in how blood cultures are collected have been shown to lower the percent contamination. These will be discussed in this presentation.

    Learning Objectives:
    After Completing this activity, the learner will be able to:

    1. Discuss the three interventions that have been shown to lower blood culture contamination
    2. Discuss what a PICO based evidence-review means
    3. Discuss the target for lowering blood culture contamination at their own institution


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    MAY 28, 2014 1:30 PM PDT

    Lowering Blood Culture Contamination Rates Using an Evidence-Based Medicine Approach


    Specialty

    Laboratory Testing

    Molecular Diagnostics

    Neuron

    Microbiology

    Microbiome

    Geography

    North America67%

    Asia33%

    Registration Source

    Website Visitors100%

    Job Title

    Facility/Department Manager33%

    Medical Laboratory Technician33%

    Lab Management33%

    Organization

    Hospital67%

    Industrial Company33%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more